Latest News for: Executive nda

Edit

Best Penny Stocks to Buy on Robinhood Right Now? 4 To Check Out

PennyStocks 16 May 2021
Remy Luthringer, Executive Chairman and CEO of Minerva ... It submitted a New Drug Application or NDA to the U.S ... “Akebia is off to a great start in 2021, building positive momentum with solid execution on strategic priorities that set the stage for an exciting year.
Edit

Forma Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

The Marshall News Messenger 14 May 2021
... and the timing associated with the initiation or continuation of any trials and success of ongoing clinical trials of FT-4202 and FT-7051; Forma’s ability to execute on its strategy; the submission and acceptance of a new drug application (NDA) for submission to the U.S.
Edit

Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update

News-Press Now 13 May 2021
... Chief Executive Officer of Achieve. "We will continue to focus our efforts on execution of the Phase 3, ensuring all required NDA-enabling activities remain on track, and furthering our discussions with potential strategic partners to prepare for cytisinicline commercialization.".
Edit

These Reddit Penny Stocks Are Soaring Today, Are They Worth Buying?

PennyStocks 12 May 2021
3 Reddit Penny Stocks to Watch in May 2021 ... (NASDAQ ... “Akebia is off to a great start in 2021, building positive momentum with solid execution on strategic priorities that set the stage for an exciting year. Most importantly, we submitted the vadadustat NDA to the FDA, a significant milestone for Akebia and our new partner, Otsuka Pharmaceutical Co.
Edit

Boniface Gambila isn’t just greedy, acts as the King of NPP in Nabdam – NDC MP lashes

Ghana Web 11 May 2021
Mr. Gambila has been likened to someone who behaves like a King within the NPP in Nabdam Constituency aside from claims that he is greedy ... Dr ... Dr ... However, Mr ... Mr. Gambila who is now acting as the Chief Executive Officer for Northern Development Authority (NDA) has been accused of mismanaging his Common fund during his stay in office as an MP ... .
Edit

Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones

The Maryville Daily Times 10 May 2021
"Akebia is off to a great start in 2021, building positive momentum with solid execution on strategic priorities that set the stage for an exciting year. Most importantly, we submitted the vadadustat NDA to the FDA, a significant milestone for Akebia and our partner, Otsuka Pharmaceutical Co ... Butler, Chief Executive Officer of Akebia ... NDA.
Edit

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 ...

The Marshall News Messenger 07 May 2021
“The filing of an NDA for XERAVA in China by our licensee Everest and the execution of our license agreement with PAION for GIAPREZA and XERAVA in Europe position us well to serve the needs of patients suffering from life-threatening diseases globally while significantly strengthening our balance sheet.
Edit

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress

Pharmiweb 07 May 2021
“The filing of an NDA for XERAVA in China by our licensee Everest and the execution of our license agreement with PAION for GIAPREZA and XERAVA in Europe position us well to serve the needs of patients suffering from life-threatening diseases globally while significantly strengthening our balance sheet.
Edit

Mirati Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Updates

The Maryville Daily Times 07 May 2021
SAN DIEGO, May 6, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ ... Baum, M.D., Ph.D., president and chief executive officer, Mirati Therapeutics, Inc. "We are excited to submit our first NDA with adagrasib in the second half of this year for patients with non-small cell lung cancer who have a KRASG12C mutation." ... Pipeline Updates. Adagrasib ... ( ... ).
Edit

Spero Therapeutics Announces First Quarter 2021 Operating Results and Provides Business Update

Tyler Morning Telegraph 06 May 2021
Tebipenem HBr remains on track for NDA submission in the second half of 2021 ... “We are off to a strong start in 2021 and I am very pleased with the progress we have made across our pipeline,” said Ankit Mahadevia, M.D., Chief Executive Officer of Spero Therapeutics ... NDA submission.
Edit

United Therapeutics Corporation Reports First Quarter 2021 Financial Results

Johnson City Press 05 May 2021
"2021 is already a historic year for United Therapeutics, with the recent FDA approval and launch of Tyvaso for treatment of PH-ILD, submission of the Tyvaso DPI NDA, and the launch of our Remunity® Pump for Remodulin®," said Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics.
Edit

3 Penny Stocks to Watch During the Last Week of April

PennyStocks 26 Apr 2021
Donald Kellerman, VP of Clinical Development and Medical Affairs at Zosano, stated that “we believe that this study can be executed quickly and will address the last remaining clinical request from FDA regarding the resubmission of our NDA for Qtrypta.
Edit

SBI puts up for sale NPA account MSP Metallics

Yahoo Daily News 16 Apr 2021
Read full article. 16 April 2021, 5.10 pm·2-min read ... The reserve price has been set at Rs 350 crore ... 'The interested ARCs/banks/NBFCs/FIs can conduct due diligence of these assets with immediate effect, after submitting expression of interest and executing a Non-Disclosure Agreement (NDA) with the bank,' SBI said ... PTI KPM KPM ABM ABM ... 1 ... 2.
Edit

Goa Forward Party quits NDA

The Times of India 13 Apr 2021
In a letter to NDA national chairperson Amit Shah, the said the NDA had “miserably failed” to protect Goa’s interests. The decision to quit the NDA was taken by the party’s state executive committee which met at the party headquarters on Gudi Padva, which is celebrated as the new year by Hindus.
×